Showing results (231-240 of 1,919) with videos related to
Sort By:
Pageof 192
Cancer Biomarkers : Section a of Disease Markers|January 29, 2019
Circular RNA hsa_circRNA_102958 may serve as a diagnostic marker for gastric cancerJuan Wei, Wei Wei, Hanfeng Xu, et al.Cancer Biomarkers : Section a of Disease Markers|January 8, 2019
MiR-27a promotes EMT in ovarian cancer through active Wnt/𝜷-catenin signalling by targeting FOXO1Li-Ya Zhang, Yuan Chen, Jue Jia, et al.Cancer Biomarkers : Section a of Disease Markers|January 8, 2019
The ratio of Bcl-2/Bim as a predictor of cisplatin response provides a rational combination of ABT-263 with cisplatin or radiation in small cell lung cancerHong Li, Huogang Wang, Ke Deng, et al.Cancer Biomarkers : Section a of Disease Markers|January 8, 2019
Correlations of DKK1 with pathogenesis and prognosis of human multiple myelomaYoufan Feng, Yuxia Zhang, Xiaofang Wei, et al.Cancer Biomarkers : Section a of Disease Markers|January 8, 2019
WITHDRAWN: The therapeutic role of inhibition of miR-328 on pulmonary carcinoma induced by chlamydia pneumoniae through targeting histone H2AXMingjing Shen, Lichun Cai, Kanqiu Jiang, et al.Cancer Biomarkers : Section a of Disease Markers|January 8, 2019
The association of Bcl-xL and p53 expression with survival outcomes in oropharyngeal cancerHedyeh Ziai, Abdulrahman Alenazi, Matthew Hearn, et al.Cancer Biomarkers : Section a of Disease Markers|December 31, 2018
The altered expression levels of miR-186, miR-494 and miR-3651 in OSCC tissue vary from those of the whole blood of OSCC patientsJutta Ries, Christoph Baran, Falk Wehrhan, et al.Cancer Biomarkers : Section a of Disease Markers|April 7, 2020
Molecular characterisation in tongue squamous cell carcinoma reveals key variants potentially linked to clinical outcomesAbeer A Alsofyani, Ashraf Dallol, Suha A Farraj, et al.Cancer Biomarkers : Section a of Disease Markers|April 1, 2020
FOXO1 overexpression is correlated with poor prognosis in epithelial ovarian cancerLongyang Liu, Juanjuan Yi, Jianhuan Yuan, et al.Cancer Biomarkers : Section a of Disease Markers|April 1, 2020
MiR-519a functions as a tumor suppressor and is negatively associated with poor prognosis of non-small cell lung cancerYitao Wang, Feifei Jiang, Jian Wang, et al.Pageof 192